This study systematically reviewed and quantified the relationship between exposure to antibiotics during the first 2 years of life and the risk of allergies/atopies including hay fever, eczema, food allergy, positive skin prick testing (SPT), or elevated allergen-specific serum/plasma immunoglobulin (Ig) E levels later in life.
For this meta-analysis, we followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. 47 
| Data source
We conducted a comprehensive literature search of PubMed and the Web of Science using multiple search terms shown in Table S1 .
Additional articles were retrieved through a manual search of references from included articles.
| Inclusion and exclusion criteria
Studies were included if (i) they assessed the association between antibiotics consumption during the first 2 years of life and the risk of developing hay fever, eczema, food allergy, positive SPT, or elevated allergen-specific serum/plasma IgE levels, and (ii) a quantified measurement of association between exposure and outcomes was reported as odds ratio (OR) or hazard ratio (HR) or could be calculated as OR.
Our literature search was restricted to studies published in English from January 1966 through November 11, 2015 . We excluded those studies that were limited to ever use of antibiotics (not restricted to the first 2 years of life). [44] [45] [46] 
| Clinical end points
The outcomes studied in our meta-analysis were as follows: (i) hay fever defined as any experience of allergic rhinitis such as sneezing, runny nose, nasal blockage or red and itching eyes, or any medication used for hay fever or a physician diagnosis of hay fever during the last 12 months. Three studies included children younger than 5 years where only in one study the definition of hay fever was based on hay fever symptoms and allergen-specific sensitization, 36 (ii) eczema defined as any dermatitis, for example, itching skin disease or itchy rash reported by parents or diagnosed by a physician during the last 12 months before outcome measurement, (iii) food allergy defined as any symptoms to food plus specified criteria, for example, clinical examination and a positive SPT or cow's milk allergy (with ICD-10 codes L27.2 or K52.2), (iv) a positive response to SPT, and e) increased serum/plasma specific IgE level (≥0.25 IU/mL or ≥0.3 KU/L).
| Reporting more than one risk estimate
For studies that reported ≥1 ORs/HRs for the associations between antibiotics and outcomes, we selected one effect measurement per study to include in the primary meta-analysis. The choice of the effect measurement was based on the following: (i) the shortest period of the exposure; for example, if a study reported 2 ORs/HRs-1 for antibiotics exposure within the first year of life and 1 for antibiotics exposure within the second year of life-the first yearestimated effect was included in the primary meta-analysis. Moreover, if ORs/HRs were reported for variable amounts of antibiotics (e.g, 1 course, 2 courses, 3 courses), the effect measurement of the largest sample size was included in the primary meta-analysis; (ii) the longest follow-up period for the outcome; for example, in a study that reported ORs/HRs for the association of early-life exposure to antibiotics and the occurrence of outcomes in children at the age of 4 years and children at the age of 8 years, the OR/HR associated with the outcome at 8 years was included in the primary meta-analysis.
Other reported ORs/HRs were used in subgroup meta-analyses.
| Data analysis
Overall pooled ORs, together with 95% confidence intervals (CIs) of the association between early-life exposure to antibiotics and allergies/atopies, were obtained using either a fixed-effects model or in case of heterogeneity, a random-effects model. Heterogeneity was identified using the I 2 statistic with a significance level of a = 0.05, which quantifies inconsistency across studies included: 25% corresponding to low, 50% to moderate, and 75% to high heterogeneity.
The primary meta-analyses included all studies on the association between exposure and outcomes and were run for hay fever, eczema, food allergy, positive SPT, and elevated serum/plasma IgE levels, separately.
Metaregression analyses were performed on the effect of the child's age at the time of antibiotics consumption and the age at the time of diagnosis.
To test the causal relation between antibiotics and outcomes, the second meta-analysis only included those studies that have explicitly reported that patients diagnosed with allergies/atopies are new incident cases at the time of outcome measurement.
In the third meta-analysis, the association between antibiotics and outcomes was studied by including only those studies that analyzed both allergic clinical symptoms (hay fever and eczema) and objective markers of allergy (we chose positive SPT as the most common allergy marker in individual studies) in the same patients.
Publication bias was evaluated using funnel plots where the Egger test was applied to measure any asymmetry. In this meta-analysis, for reasons of symmetry, the reported ORs and lower and upper bounds of the 95% CIs were initially log-transformed; the log ORs together with 95% CIs of the log ORs were meta-analyzed using either fixed-or random-effects models; then, the results were transformed back to the original ORs for reporting. P-values of <.05
were used to assess the statistical significance of main effect associ- 3 | RESULTS
| Systematic search results
A flowchart ( Figure 1 ) describes study identification, screening, and inclusion. Our literature search yielded 3839 published articles, and after applying the inclusion and exclusion criteria, a total of 34 studies were selected for the meta-analysis.
| Study characteristics
The characteristics of the included studies are summarized in Table 1 for cohort studies (n = 20 studies), Table 2 for case-control studies (n = 6 studies), and Table 3 
| Antibiotics exposure and hay fever
Our primary meta-analysis showed a statistically significant higher risk of developing hay fever among children exposed to antibiotics during the first 2 years of life compared to never-exposed children in the same period of time 
| Publication bias
As shown in Fig. S1 , there was no evidence of asymmetry to show potential publication bias in the primary meta-analyses for eczema (P = .52), food allergy (P = .43), positive SPT (P = .14), and elevated allergen-specific serum/plasma IgE levels (P = .38). Asymmetry appeared in the funnel plot for the association between antibiotics and hay fever (P = .01). This means that small studies showing a strong association probably have not been published yet.
| Metaregression
We conducted a metaregression analysis to identify the independent effect of variables (child's age at the time of antibiotics consumption and patient's age at the time of diagnosis of allergies/atopies) on the ORs. The age at which elevated allergen-specific IgE levels were observed, was found as the only predictor of the estimated OR (Pvalue: .05). However, we tested whether any clinical manifestations of allergies including eczema or eczema and hay fever together had more weight on the results. Our results showed that none of the clinical manifestation of allergies including eczema (P = .83) or eczema and hay fever together (P = .81) affected the predictive effect of age on specific IgE serum/plasma level (Table S2 ).
| DISCUSSION
To the best of our knowledge, this systematic review and meta-ana- In cross-sectional studies, both exposure and outcome were questioned at one point of time; however, the period over which exposure and outcome were requested was different, and therefore, these studies have been accepted in our meta-analyses.
CI, confidence interval; OR, odds ratio; SPT, skin prick test; IgE, immunoglobulin E; SPT, skin prick test.
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| 979 developing allergy and atopy later in life. Our main meta-analysis (including 34 studies and 340 428 patients) showed that exposure to antibiotics during the first 2 years of life is associated with an increased risk of hay fever, eczema, and food allergy later in life.
However, remarkably, there was no association between exposure to antibiotics early in life and a positive SPT or elevated allergenspecific serum/plasma IgE levels later in life.
It remains unclear which mechanism may underlie the observed increased risk of hay fever, eczema, and food allergy among children exposed to antibiotics in early childhood. One hypothesis is that Odds ratio (95% confidence interval) F I G U R E 3 Association between earlylife exposure to antibiotics and risk of eczema later in life antibiotics have immunomodulatory effects through their action on the gut microbiota, which may influence the risk of allergic disorders. 48, 49 However, our positive results might also be explained by confounding by indication; individuals more prone to develop allergic diseases later in life might have been more prone for other conditions due to immunological incompetence requiring antibiotics use early in life. 50 In our study, antibiotic exposure was associated with an increased risk of clinical allergic manifestations, but to our surprise, not with an increased risk of allergic sensitization. This was still true when we studied these outcomes in the same patients, even though the association with hay fever was no longer statistically significant in this smaller group. However, it should be noted that there is no clear relationship between allergic sensitization and allergic symptoms. 17, [51] [52] [53] Although allergic sensitization often overlaps with the occurrence of allergic symptoms, there are also many children without allergen-specific serum IgE/positive SPT that do develop allergic symptoms 17, 19, 21, 22, 26, 31 and vice versa. 43 There might be a different 
54-56
More solid evidence for the association between antibiotics exposure and clinical manifestations of allergies would require a randomized control study, which is not feasible to perform in this setting due to ethical reasons.
There are several potential limitations in the current study that should be addressed. Firstly, study design, the methods to analyze the data, and confounders involved in the adjusted models are not consistent across the studies included. Cross-sectional studies are limited by the fact that they are carried out at one point in time to obtain information on all factors (exposure, outcome, and confounders). Therefore, no conclusions about causal relationships can be drawn from studies with this design. However, in the self-defined cross-sectional studies that we have included in our meta-analysis (Table 3) , the exposure to antibiotics was requested from a period in the past. Immunodeficiencies of childhood are a common cause for both infections and allergic disorders; these are potential confounders that have not been taken into account in studies included in the meta-analysis. There was a high degree of heterogeneity in patient's characteristics, for example, child's age at the time of antibiotics consumption and patient's age at the time of outcome measurement. These heterogeneities might have contributed to the discrepant results reported by previous epidemiological studies.
However, our results were robust and consistent across the different subset of studies, for example, distinct study designs and different patient's characteristics. In pediatric allergic or atopic-related disorders, the timing of antibiotics consumption might be of importance,
in which the first 6 months of life has been suggested to be the | 981 critical period. 57 The association of exposure to antibiotics in 3-week-old mice with increased risk of atopies measured by IgE serum levels has been already shown. 58 In addition, Wickens et al. have shown the significantly increased risk of positive SPT in children exposed to antibiotics during the first 3 months. 43 Although in our meta-analysis we were limited to test this association in the first 3 months (low number of studies included), we found very similar results for this association in the first 6 months of exposure to antibiotics (data not shown).
As presented in Figure 2 , there is heterogeneity in the results of association between antibiotics and hay fever in the primary studies in which the association is not statistically significant in 12 studies included in our meta-analysis. However, the point estimates in 67% of these studies (8 of 12 studies) are above 1 and the 95% confidence intervals of all these 23 studies largely overlapped. Some of these individual studies may have been underpowered to identify a significant association due to small sample size. Furthermore, the differences in outcome definitions and more importantly differences in the ages of the children at the time of hay fever diagnosis in these studies might also explain the observed heterogeneity. Finally, one cannot rule out a possibility of imprecise diagnosis, in particular, of hay fever symptoms.
Dealing with heterogeneity was limited in the association between antibiotics and risk of food allergy. Studies selected for this association were extremely heterogeneous, most importantly, in the definition of the outcome. Food allergy is phenotypically a very wide-ranging group of diseases, which is often confused with other disorders, for example, celiac disease. 59 To confirm the significant positive association reported by our study, further research is needed.
Another important limitation consists of poor reporting of the types and the amount of antibiotics courses taken; this was often not mentioned in the studies. Previous studies reported that early use of broad-spectrum antibiotics was more strongly related to an altered gut microbiome and therefore the increased risk of allergies compared with narrow-spectrum antibiotics. 12, 15, 18, 23, 27, 28, 37 Unfortunately, we could not study the difference between broad-and narrow-spectrum antibiotics because the number of studies that Odds ratio (95% confidence interval) F I G U R E 5 Association between early-life exposure to antibiotics and risk of positive skin prick test later in life reported the association stratified by type of antibiotics was not sufficient. The present study was also limited by including studies that used the parental-reported exposure to antibiotics (n = 23), which might be prone to recall bias. Parents may not always be able to remember and give accurate information on their child's medication use especially when the time of exposure is long ago. However, the results of our subgroup meta-analyses, separately for each outcome, showed no significant difference between the pooled effect estimates in studies with parental-reported measurement of antibiotics compared with medical/pharmacy record-based studies.
Moreover, hay fever, eczema, and food allergy were based on subjective symptoms and not objectively measured in a number of studies (n = 25); therefore, there is a risk of misclassification. For instance, the definition of hay fever/allergic rhinitis was not based on skin testing and/or evaluation of specific IgE; this might result in a misclassification of this outcome especially in children younger than 5 years who are prone to upper respiratory tract infections.
Nevertheless, results of our study were similar to studies that used questionnaire-based outcomes compared with studies that used medical record-based outcomes.
In sensitivity analyses, we could only include parental allergy which is known to have a large impact on the association between antibiotics and allergy. 36 Although various variables may impact the risk of developing allergic disorders, not all these variables were available in the distinct studies.
The putative association between antibiotics and allergies could be caused by reverse causation in which children were prescribed antibiotics to treat symptoms related to allergies. Only 11 of 34 studies included explicitly reported that the use of antibiotics preceded the diagnosis of allergies. 10, 12, 16, 18, 21, [25] [26] [27] 37, 38, 43 In our meta-analysis, we tested the association between antibiotics and risk of hay fever and eczema only in these 11 studies to infer causality and the results still showed a significant association.
We tested the robustness of our findings using multiple subgroup and sensitivity analyses and consistently found an association between antibiotics exposure early in life and hay fever, eczema, and food allergy later in life. However, it remains unclear what causes this association. Further research into the impact of antibiotics on gut microbiome and related immune fitness is warranted.
As inappropriate use of antibiotics in children is a major public health issue, 60 we strongly suggest more attention to improve healthcare quality by defining prognostic and diagnostic markers and recognizing children who never benefited from antibiotics therapy, for example, those with the diagnosis of influenza. 61 Additionally, it is important to focus on educational programs in both individual patients and clinicians regarding judicious use of antibiotics. 62 Intervention studies including both patient and clinician awareness have shown that the inappropriate use of antibiotics was significantly reduced, for instance, by displaying poster-sized commitment letters in examination room. 60 The appropriate use of probiotics has been shown as a plausible factor to affect the gut microbiome composition in children treated with antibiotics. 63 
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